Annual CFI
$128.38 M
+$383.45 M+150.33%
31 December 2023
Summary:
Day One Biopharmaceuticals annual cash flow from investing activities is currently $128.38 million, with the most recent change of +$383.45 million (+150.33%) on 31 December 2023. During the last 3 years, it has risen by +$128.47 million (+139641.30%). DAWN annual CFI is now at all-time high.DAWN Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
-$67.70 M
-$84.76 M-496.90%
30 September 2024
Summary:
Day One Biopharmaceuticals quarterly cash flow from investing activities is currently -$67.70 million, with the most recent change of -$84.76 million (-496.90%) on 30 September 2024. Over the past year, it has dropped by -$156.62 million (-176.14%). DAWN quarterly CFI is now -175.82% below its all-time high of $89.29 million, reached on 31 March 2024.DAWN Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
$69.03 M
-$156.62 M-69.41%
30 September 2024
Summary:
Day One Biopharmaceuticals TTM cash flow from investing activities is currently $69.03 million, with the most recent change of -$156.62 million (-69.41%) on 30 September 2024. Over the past year, it has dropped by -$26.76 million (-27.94%). DAWN TTM CFI is now -69.84% below its all-time high of $228.86 million, reached on 31 March 2024.DAWN TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
DAWN Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +150.3% | -176.1% | -27.9% |
| 3 y3 years | +10000.0% | -100.0% | +962.9% |
| 5 y5 years | - | - | - |
DAWN Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +150.3% | -175.8% | +72.6% | -69.8% | +125.9% |
| 5 y | 5 years | at high | +150.3% | -175.8% | +72.6% | -69.8% | +125.9% |
| alltime | all time | at high | +150.3% | -175.8% | +72.6% | -69.8% | +125.9% |
Day One Biopharmaceuticals Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$67.70 M(-496.9%) | $69.03 M(-69.4%) |
| June 2024 | - | $17.06 M(-80.9%) | $225.64 M(-1.4%) |
| Mar 2024 | - | $89.29 M(+193.9%) | $228.86 M(+78.3%) |
| Dec 2023 | $128.38 M(-150.3%) | $30.38 M(-65.8%) | $128.38 M(+34.0%) |
| Sept 2023 | - | $88.92 M(+338.6%) | $95.79 M(-139.9%) |
| June 2023 | - | $20.27 M(-281.1%) | -$239.98 M(-9.9%) |
| Mar 2023 | - | -$11.19 M(+406.5%) | -$266.25 M(+4.4%) |
| Dec 2022 | -$255.07 M | -$2.21 M(-99.1%) | -$255.07 M(+0.9%) |
| Sept 2022 | - | -$246.85 M(+4016.3%) | -$252.86 M(+4106.0%) |
| June 2022 | - | -$6.00 M(>+9900.0%) | -$6.01 M(>+9900.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$15.00 K(<-9900.0%) | -$15.00 K(-99.8%) |
| Dec 2021 | -$8.00 M(+8595.7%) | $0.00(0.0%) | -$8.00 M(+0.0%) |
| Sept 2021 | - | $0.00(0.0%) | -$8.00 M(0.0%) |
| June 2021 | - | $0.00(-100.0%) | -$8.00 M(-0.1%) |
| Mar 2021 | - | -$8.00 M(<-9900.0%) | -$8.00 M(+8600.0%) |
| Dec 2020 | -$92.00 K(<-9900.0%) | $1000.00(>+9900.0%) | -$92.00 K(-1.1%) |
| Sept 2020 | - | $0.00(-100.0%) | -$93.00 K(0.0%) |
| June 2020 | - | -$5000.00(-94.3%) | -$93.00 K(+5.7%) |
| Mar 2020 | - | -$88.00 K | -$88.00 K |
| Dec 2019 | $0.00 | - | - |
FAQ
- What is Day One Biopharmaceuticals annual cash flow from investing activities?
- What is the all time high annual CFI for Day One Biopharmaceuticals?
- What is Day One Biopharmaceuticals annual CFI year-on-year change?
- What is Day One Biopharmaceuticals quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Day One Biopharmaceuticals?
- What is Day One Biopharmaceuticals quarterly CFI year-on-year change?
- What is Day One Biopharmaceuticals TTM cash flow from investing activities?
- What is the all time high TTM CFI for Day One Biopharmaceuticals?
- What is Day One Biopharmaceuticals TTM CFI year-on-year change?
What is Day One Biopharmaceuticals annual cash flow from investing activities?
The current annual CFI of DAWN is $128.38 M
What is the all time high annual CFI for Day One Biopharmaceuticals?
Day One Biopharmaceuticals all-time high annual cash flow from investing activities is $128.38 M
What is Day One Biopharmaceuticals annual CFI year-on-year change?
Over the past year, DAWN annual cash flow from investing activities has changed by +$383.45 M (+150.33%)
What is Day One Biopharmaceuticals quarterly cash flow from investing activities?
The current quarterly CFI of DAWN is -$67.70 M
What is the all time high quarterly CFI for Day One Biopharmaceuticals?
Day One Biopharmaceuticals all-time high quarterly cash flow from investing activities is $89.29 M
What is Day One Biopharmaceuticals quarterly CFI year-on-year change?
Over the past year, DAWN quarterly cash flow from investing activities has changed by -$156.62 M (-176.14%)
What is Day One Biopharmaceuticals TTM cash flow from investing activities?
The current TTM CFI of DAWN is $69.03 M
What is the all time high TTM CFI for Day One Biopharmaceuticals?
Day One Biopharmaceuticals all-time high TTM cash flow from investing activities is $228.86 M
What is Day One Biopharmaceuticals TTM CFI year-on-year change?
Over the past year, DAWN TTM cash flow from investing activities has changed by -$26.76 M (-27.94%)